losartan has been researched along with bafilomycin a1 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barreto-Chaves, ML; Mello-Aires, M | 1 |
Siebelmann, M; Verspohl, EJ; Wensing, J | 1 |
Brailoiu, E; Brailoiu, GC; Deliu, E; Motoc, D; Tica, AA | 1 |
3 other study(ies) available for losartan and bafilomycin a1
Article | Year |
---|---|
Effect of luminal angiotensin II and ANP on early and late cortical distal tubule HCO3- reabsorption.
Topics: Absorption; Amiloride; Angiotensin II; Animals; Anti-Bacterial Agents; Atrial Natriuretic Factor; Bicarbonates; Biphenyl Compounds; Enzyme Inhibitors; Imidazoles; Kidney Cortex; Kidney Tubules, Distal; Losartan; Macrolides; Male; Rats; Rats, Wistar; Tetrazoles | 1996 |
The impact of ANG II and IV on INS-1 cells and on blood glucose and plasma insulin.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Animals; Blood Glucose; Blotting, Western; Cell Line; Cystinyl Aminopeptidase; Gene Expression Regulation; Glucose; Insulin; Insulin Secretion; Losartan; Macrolides; Plasminogen Activator Inhibitor 1; Protein Binding; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Transfection | 2010 |
Intracellular angiotensin II activates rat myometrium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arsenicals; Autophagy; Brefeldin A; Calcium Signaling; Carbolines; Cells, Cultured; Egtazic Acid; Endocytosis; Endoplasmic Reticulum; Endosomes; Enzyme Inhibitors; Estrenes; Female; Heparin; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Losartan; Lysosomes; Macrocyclic Compounds; Macrolides; Models, Biological; Myometrium; NADP; Oxazoles; Piperazines; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ryanodine; Saralasin; Signal Transduction; Sirolimus; Type C Phospholipases; Uterus | 2011 |